CU6 2.70% $6.13 clarity pharmaceuticals ltd

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-6

  1. 89 Posts.
    lightbulb Created with Sketch. 58
    While Russia is one of the top producers of both metals, it is not the only source of these metals so it should be fine.

    Clinical trial supply especially in Phase 1 and 2 where Clarity's products are in will not need an extensive supply so it shouldn't be a big issue.
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.